Naphazoline is a sympathomimetic substance that develops a vasoconstrictor action with a rapid decongestive effect on the inflamed mucosa of the conjunctiva.
Antazoline is a substance with antihistamine activity, normally capable of attenuating inflammatory processes caused by allergies. The association of these two active substances has proven to be effective compared to the individual components in the treatment of symptoms caused by allergic eye diseases.
It is indicated for the temporary relief of irritation, redness and mild ocular congestion of allergic origin for adults and adolescents over 12 years of age.